Pacific Biosciences of California PACB Business Segments — Income tax provision (benefit)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's business segments — income tax provision (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's business segments — income tax provision (benefit)?
- Pacific Biosciences of California (PACB) reported business segments — income tax provision (benefit) of $184K in Q1 2026.
- How has Pacific Biosciences of California's business segments — income tax provision (benefit) changed year-over-year?
- Pacific Biosciences of California's business segments — income tax provision (benefit) increased by 160.9% year-over-year, from -$302K to $184K.
- What does business segments — income tax provision (benefit) mean?
- This reflects the total tax expense or benefit recognized by the reportable segment for the period, calculated based on applicable jurisdictional tax laws. It represents the portion of the company's tax burden or credit attributable to the specific operations of this segment. Analyzing this figure is essential for understanding the segment's effective tax rate and its contribution to the company's overall tax position.